<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d140">
    <sentence id="DDI-DrugBank.d140.s0" text="The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, azole antifungals.">
        <entity charOffset="110-121" id="DDI-DrugBank.d140.s0.e0" text="cyclosporine" type="drug"/>
        <entity charOffset="124-146" id="DDI-DrugBank.d140.s0.e1" text="fibric acid derivatives" type="group"/>
        <entity charOffset="149-154" id="DDI-DrugBank.d140.s0.e2" text="niacin" type="drug"/>
        <entity charOffset="157-170" id="DDI-DrugBank.d140.s0.e3" text="nicotinic acid" type="drug"/>
        <entity charOffset="174-185" id="DDI-DrugBank.d140.s0.e4" text="erythromycin" type="drug"/>
        <entity charOffset="188-204" id="DDI-DrugBank.d140.s0.e5" text="azole antifungals" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e0" e2="DDI-DrugBank.d140.s0.e1" id="DDI-DrugBank.d140.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e0" e2="DDI-DrugBank.d140.s0.e2" id="DDI-DrugBank.d140.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e0" e2="DDI-DrugBank.d140.s0.e3" id="DDI-DrugBank.d140.s0.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e0" e2="DDI-DrugBank.d140.s0.e4" id="DDI-DrugBank.d140.s0.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e0" e2="DDI-DrugBank.d140.s0.e5" id="DDI-DrugBank.d140.s0.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e1" e2="DDI-DrugBank.d140.s0.e2" id="DDI-DrugBank.d140.s0.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e1" e2="DDI-DrugBank.d140.s0.e3" id="DDI-DrugBank.d140.s0.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e1" e2="DDI-DrugBank.d140.s0.e4" id="DDI-DrugBank.d140.s0.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e1" e2="DDI-DrugBank.d140.s0.e5" id="DDI-DrugBank.d140.s0.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e2" e2="DDI-DrugBank.d140.s0.e3" id="DDI-DrugBank.d140.s0.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e2" e2="DDI-DrugBank.d140.s0.e4" id="DDI-DrugBank.d140.s0.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e2" e2="DDI-DrugBank.d140.s0.e5" id="DDI-DrugBank.d140.s0.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e3" e2="DDI-DrugBank.d140.s0.e4" id="DDI-DrugBank.d140.s0.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e3" e2="DDI-DrugBank.d140.s0.e5" id="DDI-DrugBank.d140.s0.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s0.e4" e2="DDI-DrugBank.d140.s0.e5" id="DDI-DrugBank.d140.s0.p14"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s1" text="Antacid: When atorvastatin and Maalox TC suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%.">
        <entity charOffset="0-6" id="DDI-DrugBank.d140.s1.e0" text="Antacid" type="group"/>
        <entity charOffset="14-25" id="DDI-DrugBank.d140.s1.e1" text="atorvastatin" type="drug"/>
        <entity charOffset="31-39" id="DDI-DrugBank.d140.s1.e2" text="Maalox TC" type="brand"/>
        <entity charOffset="98-109" id="DDI-DrugBank.d140.s1.e3" text="atorvastatin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s1.e0" e2="DDI-DrugBank.d140.s1.e1" id="DDI-DrugBank.d140.s1.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s1.e0" e2="DDI-DrugBank.d140.s1.e2" id="DDI-DrugBank.d140.s1.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s1.e0" e2="DDI-DrugBank.d140.s1.e3" id="DDI-DrugBank.d140.s1.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s1.e1" e2="DDI-DrugBank.d140.s1.e2" id="DDI-DrugBank.d140.s1.p3" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s1.e1" e2="DDI-DrugBank.d140.s1.e3" id="DDI-DrugBank.d140.s1.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s1.e2" e2="DDI-DrugBank.d140.s1.e3" id="DDI-DrugBank.d140.s1.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s2" text="However, LDL-C reduction was not altered."><negationtags>However, LDL-C reduction was &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; altered. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d140.s3" text="Antipyrine: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.">
        <entity charOffset="0-9" id="DDI-DrugBank.d140.s3.e0" text="Antipyrine" type="drug"/>
        <entity charOffset="20-31" id="DDI-DrugBank.d140.s3.e1" text="atorvastatin" type="drug"/>
        <entity charOffset="73-82" id="DDI-DrugBank.d140.s3.e2" text="antipyrine" type="drug"/>
        <entity charOffset="109-113" id="DDI-DrugBank.d140.s3.e3" text="drugs" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s3.e0" e2="DDI-DrugBank.d140.s3.e1" id="DDI-DrugBank.d140.s3.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s3.e0" e2="DDI-DrugBank.d140.s3.e2" id="DDI-DrugBank.d140.s3.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s3.e0" e2="DDI-DrugBank.d140.s3.e3" id="DDI-DrugBank.d140.s3.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s3.e1" e2="DDI-DrugBank.d140.s3.e2" id="DDI-DrugBank.d140.s3.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s3.e1" e2="DDI-DrugBank.d140.s3.e3" id="DDI-DrugBank.d140.s3.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s3.e2" e2="DDI-DrugBank.d140.s3.e3" id="DDI-DrugBank.d140.s3.p5"/>
    <negationtags>Antipyrine: Because atorvastatin does &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d140.s4" text="Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered.">
        <entity charOffset="0-9" id="DDI-DrugBank.d140.s4.e0" text="Colestipol" type="drug"/>
        <entity charOffset="37-48" id="DDI-DrugBank.d140.s4.e1" text="atorvastatin" type="drug"/>
        <entity charOffset="83-92" id="DDI-DrugBank.d140.s4.e2" text="colestipol" type="drug"/>
        <entity charOffset="98-109" id="DDI-DrugBank.d140.s4.e3" text="atorvastatin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s4.e0" e2="DDI-DrugBank.d140.s4.e1" id="DDI-DrugBank.d140.s4.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s4.e0" e2="DDI-DrugBank.d140.s4.e2" id="DDI-DrugBank.d140.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s4.e0" e2="DDI-DrugBank.d140.s4.e3" id="DDI-DrugBank.d140.s4.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s4.e1" e2="DDI-DrugBank.d140.s4.e2" id="DDI-DrugBank.d140.s4.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s4.e1" e2="DDI-DrugBank.d140.s4.e3" id="DDI-DrugBank.d140.s4.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s4.e2" e2="DDI-DrugBank.d140.s4.e3" id="DDI-DrugBank.d140.s4.p5" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s5" text="However, LDL-C reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone.">
        <entity charOffset="42-53" id="DDI-DrugBank.d140.s5.e0" text="atorvastatin" type="drug"/>
        <entity charOffset="59-68" id="DDI-DrugBank.d140.s5.e1" text="colestipol" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s5.e0" e2="DDI-DrugBank.d140.s5.e1" id="DDI-DrugBank.d140.s5.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s6" text="Cimetidine: Atorvastatin plasma concentrations and LDL-C reduction were not altered by coadministration of cimetidine.">
        <entity charOffset="0-9" id="DDI-DrugBank.d140.s6.e0" text="Cimetidine" type="drug"/>
        <entity charOffset="12-23" id="DDI-DrugBank.d140.s6.e1" text="Atorvastatin" type="drug"/>
        <entity charOffset="107-116" id="DDI-DrugBank.d140.s6.e2" text="cimetidine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s6.e0" e2="DDI-DrugBank.d140.s6.e1" id="DDI-DrugBank.d140.s6.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s6.e0" e2="DDI-DrugBank.d140.s6.e2" id="DDI-DrugBank.d140.s6.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s6.e1" e2="DDI-DrugBank.d140.s6.e2" id="DDI-DrugBank.d140.s6.p2"/>
    <negationtags>Cimetidine: Atorvastatin plasma concentrations and LDL-C reduction were &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; altered by coadministration of cimetidine. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d140.s7" text="Digoxin: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.">
        <entity charOffset="0-6" id="DDI-DrugBank.d140.s7.e0" text="Digoxin" type="drug"/>
        <entity charOffset="32-43" id="DDI-DrugBank.d140.s7.e1" text="atorvastatin" type="drug"/>
        <entity charOffset="49-55" id="DDI-DrugBank.d140.s7.e2" text="digoxin" type="drug"/>
        <entity charOffset="98-104" id="DDI-DrugBank.d140.s7.e3" text="digoxin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s7.e0" e2="DDI-DrugBank.d140.s7.e1" id="DDI-DrugBank.d140.s7.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s7.e0" e2="DDI-DrugBank.d140.s7.e2" id="DDI-DrugBank.d140.s7.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s7.e0" e2="DDI-DrugBank.d140.s7.e3" id="DDI-DrugBank.d140.s7.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s7.e1" e2="DDI-DrugBank.d140.s7.e2" id="DDI-DrugBank.d140.s7.p3" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s7.e1" e2="DDI-DrugBank.d140.s7.e3" id="DDI-DrugBank.d140.s7.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s7.e2" e2="DDI-DrugBank.d140.s7.e3" id="DDI-DrugBank.d140.s7.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s8" text="Patients taking digoxin should be monitored appropriately.">
        <entity charOffset="16-22" id="DDI-DrugBank.d140.s8.e0" text="digoxin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s9" text="Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.">
        <entity charOffset="0-11" id="DDI-DrugBank.d140.s9.e0" text="Erythromycin" type="drug"/>
        <entity charOffset="63-74" id="DDI-DrugBank.d140.s9.e1" text="atorvastatin" type="drug"/>
        <entity charOffset="129-140" id="DDI-DrugBank.d140.s9.e2" text="atorvastatin" type="drug"/>
        <entity charOffset="146-157" id="DDI-DrugBank.d140.s9.e3" text="erythromycin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s9.e0" e2="DDI-DrugBank.d140.s9.e1" id="DDI-DrugBank.d140.s9.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s9.e0" e2="DDI-DrugBank.d140.s9.e2" id="DDI-DrugBank.d140.s9.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s9.e0" e2="DDI-DrugBank.d140.s9.e3" id="DDI-DrugBank.d140.s9.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s9.e1" e2="DDI-DrugBank.d140.s9.e2" id="DDI-DrugBank.d140.s9.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s9.e1" e2="DDI-DrugBank.d140.s9.e3" id="DDI-DrugBank.d140.s9.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s9.e2" e2="DDI-DrugBank.d140.s9.e3" id="DDI-DrugBank.d140.s9.p5" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s10" text="Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.">
        <entity charOffset="5-18" id="DDI-DrugBank.d140.s10.e0" text="Contraceptives" type="group"/>
        <entity charOffset="41-52" id="DDI-DrugBank.d140.s10.e1" text="atorvastatin" type="drug"/>
        <entity charOffset="66-78" id="DDI-DrugBank.d140.s10.e2" text="contraceptive" type="group"/>
        <entity charOffset="105-117" id="DDI-DrugBank.d140.s10.e3" text="norethindrone" type="drug"/>
        <entity charOffset="123-139" id="DDI-DrugBank.d140.s10.e4" text="ethinyl estradiol" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s10.e0" e2="DDI-DrugBank.d140.s10.e1" id="DDI-DrugBank.d140.s10.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s10.e0" e2="DDI-DrugBank.d140.s10.e2" id="DDI-DrugBank.d140.s10.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s10.e0" e2="DDI-DrugBank.d140.s10.e3" id="DDI-DrugBank.d140.s10.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s10.e0" e2="DDI-DrugBank.d140.s10.e4" id="DDI-DrugBank.d140.s10.p3"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s10.e1" e2="DDI-DrugBank.d140.s10.e2" id="DDI-DrugBank.d140.s10.p4" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s10.e1" e2="DDI-DrugBank.d140.s10.e3" id="DDI-DrugBank.d140.s10.p5" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s10.e1" e2="DDI-DrugBank.d140.s10.e4" id="DDI-DrugBank.d140.s10.p6" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s10.e2" e2="DDI-DrugBank.d140.s10.e3" id="DDI-DrugBank.d140.s10.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s10.e2" e2="DDI-DrugBank.d140.s10.e4" id="DDI-DrugBank.d140.s10.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s10.e3" e2="DDI-DrugBank.d140.s10.e4" id="DDI-DrugBank.d140.s10.p9"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s11" text="These increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin.">
        <entity charOffset="60-72" id="DDI-DrugBank.d140.s11.e0" text="contraceptive" type="group"/>
        <entity charOffset="93-104" id="DDI-DrugBank.d140.s11.e1" text="atorvastatin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s11.e0" e2="DDI-DrugBank.d140.s11.e1" id="DDI-DrugBank.d140.s11.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s12" text="Warfarin: Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.">
        <entity charOffset="0-7" id="DDI-DrugBank.d140.s12.e0" text="Warfarin" type="drug"/>
        <entity charOffset="10-21" id="DDI-DrugBank.d140.s12.e1" text="Atorvastatin" type="drug"/>
        <entity charOffset="128-135" id="DDI-DrugBank.d140.s12.e2" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s12.e0" e2="DDI-DrugBank.d140.s12.e1" id="DDI-DrugBank.d140.s12.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s12.e0" e2="DDI-DrugBank.d140.s12.e2" id="DDI-DrugBank.d140.s12.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s12.e1" e2="DDI-DrugBank.d140.s12.e2" id="DDI-DrugBank.d140.s12.p2"/>
    <negationtags>Warfarin: Atorvastatin had &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d140.s13" text="Endocrine Function HMG-CoA reductase inhibitors interfere with cholesterol synthesis and theoretically might blunt adrenal and/or gonadal steroid production.">
        <entity charOffset="19-46" id="DDI-DrugBank.d140.s13.e0" text="HMG-CoA reductase inhibitors" type="group"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s14" text="Clinical studies have shown that atorvastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve.">
        <entity charOffset="33-44" id="DDI-DrugBank.d140.s14.e0" text="atorvastatin" type="drug"/>
    <negationtags>Clinical studies have shown that atorvastatin does &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; reduce basal plasma cortisol concentration or impair adrenal reserve. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d140.s15" text="The effects of HMG-CoA reductase inhibitors on male fertility have not been studied in adequate numbers of patients.">
        <entity charOffset="15-42" id="DDI-DrugBank.d140.s15.e0" text="HMG-CoA reductase inhibitors" type="group"/>
    <negationtags>The effects of HMG-CoA reductase inhibitors on male fertility have &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been studied in adequate numbers of patients. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d140.s16" text="The effects, if any, on the pituitary-gonadal axis in premenopausal women are unknown."/>
    <sentence id="DDI-DrugBank.d140.s17" text="Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine.">
        <entity charOffset="34-60" id="DDI-DrugBank.d140.s17.e0" text="HMG-CoA reductase inhibitor" type="group"/>
        <entity charOffset="184-195" id="DDI-DrugBank.d140.s17.e1" text="ketoconazole" type="drug"/>
        <entity charOffset="198-211" id="DDI-DrugBank.d140.s17.e2" text="spironolactone" type="drug"/>
        <entity charOffset="218-227" id="DDI-DrugBank.d140.s17.e3" text="cimetidine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s17.e0" e2="DDI-DrugBank.d140.s17.e1" id="DDI-DrugBank.d140.s17.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s17.e0" e2="DDI-DrugBank.d140.s17.e2" id="DDI-DrugBank.d140.s17.p1" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d140.s17.e0" e2="DDI-DrugBank.d140.s17.e3" id="DDI-DrugBank.d140.s17.p2" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s17.e1" e2="DDI-DrugBank.d140.s17.e2" id="DDI-DrugBank.d140.s17.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s17.e1" e2="DDI-DrugBank.d140.s17.e3" id="DDI-DrugBank.d140.s17.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d140.s17.e2" e2="DDI-DrugBank.d140.s17.e3" id="DDI-DrugBank.d140.s17.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d140.s18" text="CNS Toxicity Brain hemorrhage was seen in a female dog treated for 3 months at 120 mg/kg/day."/>
    <sentence id="DDI-DrugBank.d140.s19" text="Brain hemorrhage and optic nerve vacuolation were seen in another female dog that was sacrificed in moribund condition after 11 weeks of escalating doses up to 280 mg/kg/day."/>
    <sentence id="DDI-DrugBank.d140.s20" text="The 120 mg/kg dose resulted in a systemic exposure approximately 16 times the human plasma area-under-the-curve (AUC, 0-24 hours) based on the maximum human dose of 80 mg/day."/>
    <sentence id="DDI-DrugBank.d140.s21" text="A single tonic convulsion was seen in each of 2 male dogs (one treated at 10 mg/kg/day and one at 120 mg/kg/day) in a 2-year study."/>
    <sentence id="DDI-DrugBank.d140.s22" text="No CNS lesions have been observed in mice after chronic treatment for up to 2 years at doses up to 400 mg/kg/day or in rats at doses up to 100 mg/kg/day."><negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; CNS lesions have been observed in mice after chronic treatment for up to 2 years at doses up to 400 mg/kg/day or in rats at doses up to 100 mg/kg/day. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d140.s23" text="These doses were 6 to 11 times (mouse) and 8 to 16 times (rat) the human AUC (0-24) based on the maximum recommended human dose of 80 mg/day."/>
    <sentence id="DDI-DrugBank.d140.s24" text="CNS vascular lesions, characterized by perivascular hemorrhages, edema, and mononuclear cell infiltration of perivascular spaces, have been observed in dogs treated with other members of this class."/>
    <sentence id="DDI-DrugBank.d140.s25" text="A chemically similar drug in this class produced optic nerve degeneration (Wallerian degeneration of retinogeniculate fibers) in clinically normal dogs in a dose-dependent fashion at a dose that produced plasma drug levels about 30 times higher than the mean drug level in humans taking the highest recommended dose."/>
</document>